Penn Medicine Abramson Cancer Center


 

ASH 2019 Update on AML: Frontline Regimen Driven by Genetic Subgroups Both For Prognosis and Therapy Choice

12 views
February 24, 2020
0 Comments
Login to view comments. Click here to Login